News
EPHMRA - New Member
EPHMRA is pleased to welcome - PEOPLE the research partner - to the EPHMRA community as an Agency member.
Great to have you on board and looking forward to our collaboration.
Business Impact Award Winner - As sponsored by Adelphi
Business Impact:
Developing a clinical trial engagement strategy to make Boehringer Ingelheim the sponsor of choice for sites and patients: Christopher Recaldin, Associate Director at Branding Science & Kim Kallsen, Global Head of Patient and Site Engagement at Boehringer Ingelheim.
Innovative Approach Award Winner - As sponsored by AplusA
The 2022 Winner of the Innovative Approach:
Novel Approaches to Engagement: Finding and Leveraging the Patient Voice: Kate Melbourne, Director, Insights & Strategy and Dominique Cummuta, Manager, Insights & Strategy, BioVid
Future Leaders Award as sponsored by Blueprint Partnership
The 2022 Winner of the Future Leaders Case Study Award:
Focusing in on rare disease drug development: 3 case studies at different stages of the drug life cycle: Sarah Cooper Executive, Branding Science Group.
EPHMRA is pleased to...
Welcome Partners4Access to the EPHMRA community as an Agency Member.
Great to have you on board and looking forward to our collaboration.
We have 5 fantastic panellists for the EPHMRA panel discussion on The Future of Work:Life Balance.
Our session will focus on these changes and the impact they have on people and organisations.
5 May at 12 noon – 13.00 UK time
Registrations are coming on for the 11th Germany Chapter meeting for 2022 which is being held online.
EPHMRA Panel Discussion - The Future of Work/Life Balance from the Learning & Development Committee
5 May at 12 noon – 13.00 UK time
June Newsletter - Company News Update
For our June Newsletter - please do send us your company news - about people or services you would like to announce. We produce our News in pdf format for the website - and we have over 3000 contacts on our international healthcare market research database.
Germany Chapter meeting – Social Listening Panel Discussion – at 15.25 (CET) on 12 May
Join our Panellists:
Yannick Rieder, Janssen-Cilag GmbH; Christophe Petersen, Roche; Yannick Loonus, Semalytix and Stefan Maas, Ipsos GmbH